Glucagon-like peptide-1 is an incretin hormone released from the L-cells in the lining of our intestines, primarily in response to food intake
The Treat and Reduce Obesity Act was reintroduced to the Senate this past summer, but so far it has not been passed into law, Dr
Participants received diet (500 kcal deficit per day) and exercise counseling during 2-week run-in, before being randomly assigned (with a telephone or web-based system) to once-daily subcutaneous liraglutide (1.2, 1.8, 2.4 or 3.0 mg, n =9095), placebo ( n =98) or open-label orlistat (120 mg 3, n =95)
doi:10.1007/s11064-020-03030-1
Patient Profile Your appropriate adolescent patients living with obesity can benefit from Wegovy Brittany wants to start her weight-loss journey before starting college Brittany, 16 Medical history Living with obesity for 3 years Family history of diabetes and dyslipidemia Physician notes Previous attempts to implement a structured weight-management plan (diet and exercise) Patient says she feels hungry all the time Clinical Observations Physical examination BMI (kg/m 2 ) BMI Percentile 33 97 Actor portrayal